Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
Forum Spectra7 Microsystems geopend
Volgen
Hey steve, zit je nog in spectra 7, wat zijn volgens jou de vooruitzichten, gaat het nog van de grond komen of moeten we nog een tijdje wachten. Grtz
www.spectra7.com/spectra7-announces-5... Spectra7 Announces 50% Y-o-Y Revenue Growth in First Quarter 2023, Affirms Outlook for Q2 2023: “Based on these activities and indications that supply availability will improve steadily throughout 2023 and support a return to higher margins, we have established a goal of EBITDA3 profitability by the end of the year”
Nieuwe Presentatie. Toekomt ziet er goed uit. Nu alleen nog 800G Noord Amerikaanse bestellingen
Just listened to the call again in my car. Bonnie and Raouf really expressed the 'proven' technology of S7. Well, with a investment like LWLG in my portfolio for 15 years, this is indeed valuable to have. Been able to sell your tech to Sony and doing everything to keep that customer happy is not to be underestimated. Bonnie emphasized this clearly. David, Tencent was again named as a customer. As with the 800G servers speeds for DC's upgrades; due to covid it was slowed down but customers are willing now to skip 400G and go for 800G servers. It's a big jump in voltage use. Bonnie showed the graph comparing those AECs with ACCs. It really was a great call, imo They showed competence in securing chips to Sony. Keep that customer happy while killing their margins temporarily. Having margins restored is imo showing they are very committed in making S7 a success. Bite the bullet. With that experience and expertise I'm sure they can sell their ACCs to Microsoft too. This is a very cheap stock, imo
Ik heb de laatste presentatie net op het Youtube kanaal van Steve bekeken. De toekomst ziet er goed uit. Goed optreden ook van Bonnie. Dit doet zij een stuk beter dan een tijd geleden. 100k aandelen heb ik in de loop der jaren verzameld. Het wordt alles of niets!
Wat denk je, het blijft toch zowat aanmodderen, heb ook een groot pak aandelen. hopelijk tegen 4de q zdat we het zien stijgen.
Dit is gewoon het verhaal van het juiste product op een te vroeg moment. Ik kijk zoals iedereen vooruit naar Q3, eerder Q4 van dit jaar wanneer die datacenters nu eindelijk eens grotere orders gaan plaatsen. Gelukkig doet PSVR2 het goed en zorgt ervoor dat we zonder al te veel kans op verdere verwatering kunnen doorploeteren. Ik ben nog steeds hoopvol dat dit allemaal in ons voordeel zal uitdraaien. De lage volumes is gewoon het bewijs dat beleggers verder afwachten. HOLD! Ze zullen wel komen wanneer het verhaal duidelijker wordt. Met LWLG ook mee gemaakt
Zeer interessante ontwikkeling voor Spectra7. Stevige connectie ontdekt met Nvidia via hun partner Volex. Microsoft is een klant.investorshub.advfn.com/boards/read_ms...
Er wordt lekker gedumpt nu. Is dit een (slechte) voorbode van Q2-cijfers?
Ik heb stevig opnieuw ingekocht. We staan terug op 0.70$
Tue, August 22, 2023 at 1:30 PM GMT+2 In this article: SPVNF -10.2845% Watchlist Record H1 2023 Revenue and Gross Margin at 63% SAN JOSE, Calif., Aug. 22, 2023 /PRNewswire/ -- (TSXV:SEV) (OTCQB:SPVNF) Spectra7 Microsystems Inc. ("Spectra7" or the "Company"), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, today announced its financial results for the three and six months ended June 30, 2023. A copy of the consolidated financial statements for the three and six months ended June 30, 2023 and the corresponding management's discussion and analysis (the "MD&A") will be available under the Company's profile on www.sedarplus.ca. Unless otherwise indicated, all dollar amounts in this press release are expressed in US dollars. (PRNewsfoto/Spectra7 Microsystems Inc.) (PRNewsfoto/Spectra7 Microsystems Inc.) "We are excited to report second quarter revenue of $3.3 million, and record first half revenue of $6.4 million, as we continue to build on our exceptional growth in 2022. Gross margin also remained much stronger year-over-year, at 63% in the second quarter.2 While these results demonstrate exciting progress, we remain focused on the larger growth opportunities we see immediately ahead," said Raouf Halim, Chief Executive Officer. "The rising demands of increasingly power and data intensive applications such as AI and ChatGPT are mandating that our hyperscale data center partners and customers implement new 800G and 1.6TB standards for which our Active Copper Cable (ACC) technologies provide the perfect balance of high speed, low cost and low power.1 Test and qualification activities centered around these 800G and 1.6TB data rate interconnect upgrades are increasing quickly – with particular attention to Spectra7's ACC solutions to meet top-of-the-rack and short-run connectivity requirements. We expect this process will generate orders from key data center customers in North America by late 2023.1 The ACC connectivity market opportunity is estimated to reach $1 billion by 2027.3 "As an early sign of our potential for success in this market, Spectra7 is currently engaged with one of the major data center operators to deploy our ACC solutions in their AI clusters, which we expect will drive revenue growth in the coming quarters and provide additional validation of the benefits for deploying ACC solutions,"1 said Mr. Halim. Second quarter 2023 financial highlights Second quarter 2023 revenue of $3.3 million, and $6.4 million through the first six months of 2023. Gross margin2 as a percentage of revenue in the second quarter increased to 63%, from 43% in the same quarter in the prior year. Non-IFRS operating expenses4 were $2.4 million in the second quarter, similar to $2.4 million in the same quarter in the prior year as the Company continues to maintain a cost-efficient operating approach. Basic and diluted loss per share for the second quarter was $(0.03), compared to a basic and diluted loss per share of $(0.05) in the same period a year ago. EBITDA5 loss in the second quarter was $148,000, compared with an EBITDA loss of $600,000 in the same period a year ago. 2H 2023 Outlook1 The Company anticipates revenue for second half of 2023 to be in the range of $5.5 million to $7.0 million. The Company also anticipates maintaining its efficient operating expense structure and non-IFRS operating expenses4 for the 2H 2023 at a range of $4.5 million and $4.9 million. Notes: 1 This is forward-looking information and is based on a number of assumptions, which include the current and anticipated customer purchase orders received, supply outlook and anticipated operational expenditures. See "Cautionary Notes". 2 Gross margin is a non-GAAP measure which is computed as revenue less cost of sales divided by revenue. Refer to "Revenue and Gross Margin" in the MD&A, which is available on SEDAR at www.sedarplus.ca , for a reconciliation to measures reported in the Company's financial statements. 3 Spectra7 internally generated model based on 650Group silicon chipsets for Ethernet optical transceivers and active cable alternatives posted July 2023. 4 Non-IFRS operating expenses is a non-GAAP measure which includes research and development, sales and marketing, general and administrative expenses and depreciation and amortization for capital equipment and right-of-use assets and excludes share-based compensation expenses, non-recurring termination costs, interest and related financing costs, change in fair value of warrant liabilities, foreign exchange gain/loss and gain/loss from property and equipment disposal. Refer to "Non-GAAP Measures" in the MD&A, which is available on SEDAR at www.sedarplus.ca , for a reconciliation to measures reported in the Company's financial statements in the previous quarter. 5 EBITDA or earnings before interest, tax, depreciation, and amortization is a non-GAAP measure. EBITDA excludes share-based compensation, amortization, depreciation, interest, and tax expenses. Refer to "Non-GAAP Measures" in the MD&A for reconciliation to measures reported in the Company's financial statements. ABOUT SPECTRA7 MICROSYSTEMS INC. Spectra7 Microsystems Inc. is a high-performance analog semiconductor company delivering unprecedented bandwidth, speed and resolution to enable disruptive industrial design for leading electronics manufacturers in virtual reality, augmented reality, mixed reality, data centers and other connectivity markets. Spectra7 is based in San Jose, California with a design center in Cork, Ireland and a technical support location in Dongguan, China. For more information, please visit www.spectra7.com.
Ik heb net eens een vergelijking gemaakt met VUZIX (marketcap x 12), headmounted display technology. In dezelfde orde van omzet, alleen hebben ze veel meer cash. Hun outlook is niet echt zo geweldig. Zeker niet met Apple als concurrent. S7 heeft Sony als toemaatje. Spectra7 (20M marketcap) is gruwelijk ondergewaardeerd. ACCs gaan stevig ingekocht worden door Nvidia (lees Microsoft, Google en AWS). AECs blijken te duur, te veel energie en te hoge latency. Dus Credo gaat hier niet winnen. Toch niet met hun kabels, hun DSP business is met de komst van Infiniband ook niet meer zo rooskleirig. Datacenters gaan hun architecture stevig aanpassen en zich meer toespitsen op GPU's inplaats van CPU's. Allemaal door Artificiele Intelligentie. Met 341k aandelen zit ik goed denk ik. Laat Q4 maar komen
De highlights van de financiële resultaten van Spectra7 voor het tweede kwartaal van 2023 zijn: De omzet bedroeg $3,3 miljoen, een stijging van 67% ten opzichte van het eerste kwartaal van 2023 en een stijging van 1.100% ten opzichte van het tweede kwartaal van 20221. De brutowinstmarge bedroeg 63%, een verbetering ten opzichte van de 43% in het tweede kwartaal van 2022 en in lijn met de 63% in het eerste kwartaal van 20231. Het nettoverlies bedroeg $2,5 miljoen, een daling ten opzichte van het nettoverlies van $3,4 miljoen in het tweede kwartaal van 2022 en een stijging ten opzichte van het nettoverlies van $1,9 miljoen in het eerste kwartaal van 20231. De kaspositie bedroeg $4,8 miljoen per 30 juni 2023, vergeleken met $6,0 miljoen per 31 maart 20231. Het bedrijf verwacht een omzet voor de tweede helft van 2023 tussen de $5,5 miljoen en $7,0 miljoen en een niet-IFRS operationele uitgaven tussen de $4,5 miljoen en $4,9 miljoen1.
Het document bevat ook de volgende informatie: De visie van Spectra7 om de wereldwijde leider te worden in hoogwaardige halfgeleideroplossingen voor connectiviteit1. De belangrijkste differentiatoren van Spectra7, zoals de gepatenteerde GaugeChanger-technologie, de ultralage vermogensdissipatie en de kleine form factor1. De concurrentievoordelen van Spectra7, zoals de sterke intellectuele eigendomsportefeuille, de ervaren management- en technische teams en de strategische partnerschappen met toonaangevende leveranciers1. De belangrijkste risico’s en uitdagingen voor Spectra7, zoals de afhankelijkheid van een beperkt aantal klanten, de onzekerheid van de marktvraag en de concurrentiedruk1.
Spectra7 Announces Convertible Debenture Unit Financing NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES September 13th, 2023 Toronto, ON - (PR NewsWire) – (TSXV:SEV) Spectra7 Microsystems Inc. – (TSXV:SEV) (OTCQB:SPVNF) Spectra7 Microsystems Inc. (“Spectra7” or the “Company”), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, is pleased to announce a proposed private placement to certain institutional investors and insiders of the Company (the “Private Placement”) of 2,838 units of the Company (each, a “Unit”) at a price of $1,000 per Unit for aggregate gross proceeds of $2,838,000. Each Unit shall consist of one 9.0% unsecured convertible deQbenture of the Company (each, a “Debenture” and, collectively, the “Debentures”) in the principal amount of $1,000, and 1,538 common share purchase warrants of the Company (each, a “Warrant” and, collectively, the “Warrants”). Unless otherwise indicated, all dollar amounts in this press release are expressed in Canadian dollars. The Debentures will bear interest at a rate of 9.0% per annum from the issuance date (the “Issuance Date”), payable semi-annually in arrears on the last business day of June and December. The interest obligation may be satisfied either in cash or in common shares of the Company (the “Common Shares”), at the Company’s option. The Debentures will mature on the date that is two years following the Issuance Date (the “Maturity Date”) and the principal amount of each Debenture will be convertible into Common Shares at the option of the holder at any time prior to the Maturity Date, at a conversion price of $0.65 per share (the “Conversion Price”), subject to adjustment upon certain customary events. Holders converting their Debentures will receive accrued and unpaid interest thereon for the period from and including the date of the latest interest payment date to, and including, the date of conversion. Provided that the closing price of the Common Shares on the principal stock exchange on which the Common Shares trade is equal to or greater than 200% of the Conversion Price for any 10 consecutive trading days, then at any time within 30 days after such 10th consecutive trading day, the Company shall have the right, but not the obligation, to force the conversion of the principal amount of the Debentures into Common Shares at the Conversion Price in connection with a listing of the Common Shares on a recognized stock exchange in the United States or a change of control of the Company. Each Warrant will be exercisable immediately and will entitle the holder thereof to acquire one Common Share for a period of two years from the Issuance Date (the “Expiry Date”) at an exercise price equal to $0.715 per share. The Expiry Date can be accelerated by the Company at any time prior to the Expiry Date if the closing price of the Common Shares on the principal stock exchange on which the Common Shares trade is greater than $4.00 for any 10 non-consecutive trading days. The net proceeds of the Private Placement are expected to be used for working capital and general corporate purposes. A.G.P./Alliance Global Partners has agreed to act as the agent for the Private Placement. Closing of the Private Placement is subject to all necessary regulatory and stock exchange approvals, including the approval of the TSX Venture Exchange (“TSXV”). In the United States, the Units will be offered on a private placement basis pursuant to exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the “U.S. Securities Act”). All securities issuable in the Private Placement are subject to a statutory hold period until the date that is four months and one day from the date of issuance. Approval of the TSXV is required prior to any conversion of Debentures or exercise of Warrants that would result in a holder holding more than 9.9% of the issued and outstanding Common Shares and prior to the settlement of any interest payment in common shares. Pursuant to Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions (“MI 61-101”), the Private Placement constitutes a “related party transaction” as insiders of the Company are expected to subscribe for 314 Units for gross proceeds of $314,000. The Company is relying on exemptions from the formal valuation and minority approval requirements of MI 61-101. The Private Placement was approved by all of the independent directors of the Company. No securities regulatory authority has either approved or disapproved of the contents of this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This news release does not constitute an offer to sell or the solicitation of an offer to buy the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws and may not be offered or sold in the United States or to U.S. Persons unless registered under the U.S. Securities Act and any applicable state securities laws or an exemption from such registration is available. ABOUT SPECTRA7 MICROSYSTEMS INC. Spectra7 Microsystems Inc. is a high-performance analog semiconductor company delivering unprecedented bandwidth, speed and resolution to enable disruptive industrial design for leading electronics manufacturers in virtual reality, augmented reality, mixed reality, data centers and other connectivity markets. Spectra7 is based in San Jose, California with a design center in Cork, Ireland and a technical support location in Dongguan, China.
TSEM sprak ook over het gebruik van active copper cable’s. Niet veel reactie op mijn post. Tja Geduldig afwachten youtube.com/shorts/L7XHZfJssuM?si=9nK...
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Premium
Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!
Word abonnee